A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)
用户cLCxSEj5otc4
5天前
33
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-09-01 17:35:50 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.cllc.2024.12.004
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1525730424002675
其他信息:
出版社: Elsevier BV
作者: Masayuki Takeda; Masahide Ota; Eiji Iwama; Shunichi Sugawara; Takehito Shukuya; Shigeki Umemura; Hiroshi Tanaka; Masahide Oki; Takayuki Takahama; Takeshi Masuda; Naoyuki Nogami; Mototsugu Shimokawa
